Grufity logoGrufity logo

Accolade, Inc. Stock Research

ACCD

11.96USD-0.72(-5.68%)Market Closed

Market Summary

USD11.96-0.72
Market Closed
-5.68%

ACCD Stock Price

ACCD RSI Chart

ACCD Valuation

Market Cap

888.2M

Price/Earnings (Trailing)

-1.92

Price/Sales (Trailing)

2.48

EV/EBITDA

-1.35

Price/Free Cashflow

-20.87

ACCD Price/Sales (Trailing)

ACCD Profitability

EBT Margin

-129.51%

Return on Equity

-95.44%

Return on Assets

-50.75%

Free Cashflow Yield

-4.79%

ACCD Fundamentals

ACCD Revenue

Revenue (TTM)

357.9M

Revenue Y/Y

8.98%

Revenue Q/Q

3.77%

ACCD Earnings

Earnings (TTM)

-463.8M

Earnings Y/Y

-277.19%

Earnings Q/Q

14.3%

Price Action

52 Week Range

4.6119.39
(Low)(High)

Last 7 days

-6.3%

Last 30 days

7.8%

Last 90 days

43.4%

Trailing 12 Months

-14.9%

ACCD Financial Health

Current Ratio

3.14

ACCD Investor Care

Shares Dilution (1Y)

10.66%

Diluted EPS (TTM)

-6.66

Peers (Alternatives to Accolade)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.5T
387.5B
-0.56% -0.91%
25.94
6.37
2.44% -5.35%
2.1T
204.1B
-1.92% -6.89%
30.5
10.08
10.38% -5.25%
1.3T
282.8B
1.63% -25.54%
21.65
4.59
9.78% -21.12%
1.0T
514.0B
-3.36% -34.72%
-376.42
1.99
9.40% -108.16%
MID-CAP
3.6B
258.4M
203.99% 176.76%
-11.9
13.75
24.91% -254.56%
2.3B
9.2B
-18.97% -49.38%
-6.41
0.25
51.67% -98.90%
SMALL-CAP
1.7B
1.7B
-22.36% -14.62%
13.72
0.97
61.79% 371.82%
1.6B
602.5M
-17.77% -52.80%
-2.74
2.63
18.18% -18.59%
1.1B
418.9M
5.51% -56.16%
-2.93
2.57
-9.85% -101.06%
991.7M
478.9M
-11.35% -65.42%
-0.32
2.07
-31.50% -634.70%
954.9M
482.4M
-16.25% -37.64%
-4.12
1.98
33.15% -170.42%
897.6M
50.8M
-34.66% -77.56%
-1.14
17.66
1229.98% -13.59%
788.4M
1.1B
-10.56% -33.33%
27.33
0.72
-5.82% -92.23%
281.8M
10.3M
-24.84% -63.38%
-1.01
27.46
478.23% 7.85%

Financials for Accolade

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue2.1%357,873,000350,377,000336,022,000310,021,000275,497,000
Operating Expenses12.4%628,562,000559,394,000579,071,000266,727,000223,122,000
  S&GA Expenses0.4%99,204,00098,797,00097,870,00086,765,00073,004,000
EBITDA-18.7%-415,505,000-350,175,000-379,660,000-85,225,000-
EBITDA Margin-16.2%-1.16-1.00-1.13-0.27-
Earnings Before Taxes-16.5%-463,484,000-397,861,000-426,796,000-128,763,000-102,876,000
EBT Margin-14.1%-1.30-1.14-1.27-0.42-
Interest Expenses-3.6%1,589,0001,648,0001,648,000930,000930,000
Net Income-15.5%-463,773,000-401,398,000-417,239,000-123,124,000-93,294,000
Net Income Margin-13.1%-1.30-1.15-1.24-0.40-
Free Cahsflow28.5%-42,555,000-59,513,000-67,523,000-64,871,000-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-1.9%9149329441,2861,263
  Current Assets-2.3%366375378409408
    Cash Equivalents-1.5%326331336366366
  Net PPE10.2%14.0012.0012.0012.0012.00
  Goodwill0%278278278578580
Liabilities0.6%428425410430475
  Current Liabilities3.5%11711395.00112185
Shareholder's Equity-4.0%486506535856789
  Retained Earnings-4.5%-923-883-837-494-460
  Additional Paid-In Capital1.4%1,4101,3901,3721,3501,249
Shares Outstanding1.2%72.0072.0070.0067.0065.00
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations29.3%-40,430-57,160-65,197-62,350-49,670
  Share Based Compensation-0.6%81,92182,39284,65372,93949,093
Cashflow From Investing-96.9%-5,347-2,71563,827-263,613-263,572
Cashflow From Financing-16.5%5,4326,50511,490257,932260,286

Risks for ACCD

What is the probability of a big loss on ACCD?

81.7%


Probability that Accolade stock will be more than 20% underwater in next one year

75.3%


Probability that Accolade stock will be more than 30% underwater in next one year.

49.3%


Probability that Accolade stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ACCD drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Accolade was unfortunately bought at previous high price.

Drawdowns

Returns for ACCD

Cumulative Returns on ACCD

Which funds bought or sold ACCD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-06
Rockefeller Capital Management L.P.
added
37.04
-6,000
86,000
-%
2023-02-28
Voya Investment Management LLC
unchanged
-
-89,824
193,176
-%
2023-02-27
Parallax Volatility Advisers, L.P.
new
-
48,937
48,937
-%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
new
-
1,948
1,948
-%
2023-02-21
MACQUARIE GROUP LTD
sold off
-100
-18,000
-
-%
2023-02-17
EQUITABLE TRUST CO
unchanged
-
-562,394
1,207,610
0.10%
2023-02-15
JANE STREET GROUP, LLC
added
197
1,414,870
2,786,870
-%
2023-02-15
MetLife Investment Management, LLC
unchanged
-
-125,310
269,690
-%
2023-02-15
ALLIANCEBERNSTEIN L.P.
unchanged
-
-273,033
584,967
-%
2023-02-15
Metropolitan Life Insurance Co/NY
unchanged
-
-14,416
30,584
-%

1–10 of 40

Latest Funds Activity

Are funds buying ACCD calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own ACCD
No. of Funds

Accolade News

MarketBeat

100000 Shares in Accolade, Inc. (NASDAQ:ACCD) Purchased by ....

MarketBeat,
2 days ago

InvestorsObserver

Seeking Alpha

Schedule 13G FIlings of Accolade

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
bellevue group ag
5.1%
3,677,277
SC 13G
Feb 09, 2023
vanguard group inc
6.83%
4,916,397
SC 13G/A
Feb 09, 2023
brown advisory inc
6.9%
4,988,021
SC 13G
Jan 31, 2023
blackrock inc.
7.3%
5,265,682
SC 13G/A
Jan 06, 2023
jpmorgan chase & co
7.2%
5,196,148
SC 13G
Feb 14, 2022
andreessen horowitz fund iv, l.p.
2.4%
1,619,088
SC 13G/A
Feb 09, 2022
ark investment management llc
7.54%
5,029,148
SC 13G
Feb 09, 2022
vanguard group inc
7.56%
5,040,150
SC 13G
Feb 04, 2022
blackrock inc.
5.2%
3,489,312
SC 13G
Feb 16, 2021
andreessen horowitz fund iv, l.p.
2.5%
1,394,563
SC 13G

ACCD Fair Value

Recent SEC filings of Accolade

View All Filings
Date Filed Form Type Document
Mar 20, 2023
4
Insider Trading
Mar 20, 2023
4
Insider Trading
Mar 20, 2023
4
Insider Trading
Mar 20, 2023
4
Insider Trading
Mar 17, 2023
144
Notice of Insider Sale Intent
Mar 17, 2023
144
Notice of Insider Sale Intent
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Mar 02, 2023
4
Insider Trading
Feb 28, 2023
8-K
Current Report

Latest Insider Trading transactions for ACCD

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-28
BRODSKY JEFFREY S
acquired
-
-
1,207
-
2023-02-28
Klein Peter S
acquired
-
-
604
-
2023-02-17
Barnes Stephen H.
sold
-1,684
11.9464
-141
chief financial officer
2023-02-17
HILTON MICHAEL W
sold
-1,206
11.9464
-101
-
2023-02-17
Cavanaugh Robert N
sold
-2,150
11.9464
-180
president
2023-02-17
SINGH RAJEEV
sold
-3,368
11.9464
-282
chief executive officer
2023-02-16
Cavanaugh Robert N
acquired
-
-
510
president
2023-02-16
SINGH RAJEEV
acquired
-
-
933
chief executive officer
2023-02-16
Barnes Stephen H.
acquired
-
-
414
chief financial officer
2023-02-16
HILTON MICHAEL W
acquired
-
-
332
-

1–10 of 50

Rajeev Singh
2350
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

ACCD Income Statement

2022-11-30
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Nov. 30, 2022
Nov. 30, 2021
Condensed Consolidated Statements of Operations    
Revenue$ 90,946$ 83,450$ 264,117$ 216,265
Cost of revenue, excluding depreciation and amortization50,41245,156147,857125,426
Operating expenses:    
Product and technology24,25422,84677,26561,297
Sales and marketing25,02324,61675,57363,134
General and administrative20,03721,46461,29569,636
Depreciation and amortization11,60211,25034,74930,967
Goodwill impairment  299,705 
Change in fair value of contingent consideration (68,428) (38,282)
Total operating expenses80,91611,748548,587186,752
Income (loss) from operations(40,382)26,546(432,327)(95,913)
Interest income (expense), net386(743)(484)(2,137)
Other income (expense)2012521(19)
Income (loss) before income taxes(39,795)25,828(432,790)(98,069)
Income tax benefit (expense)(77)(3,325)3,5739,501
Net income (loss)$ (39,872)$ 22,503$ (429,217)$ (88,568)
Net income (loss) per share, Basic$ (0.56)$ 0.34$ (6.07)$ (1.41)
Net income (loss) per share, Diluted$ (0.56)$ 0.31$ (6.07)$ (1.41)
Weighted-average common shares outstanding, Basic71,228,35165,418,72870,755,15762,684,823
Weighted-average common shares outstanding, Diluted71,228,35171,490,04570,755,15762,684,823

ACCD Balance Sheet

2022-11-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Nov. 30, 2022
Feb. 28, 2022
Current assets:  
Cash and cash equivalents$ 325,637$ 365,853
Accounts receivable, net20,48321,116
Unbilled revenue3,7029,685
Current portion of deferred contract acquisition costs4,0753,015
Prepaid and other current assets12,3349,468
Total current assets366,231409,137
Property and equipment, net13,56111,797
Operating lease right-of-use assets30,93633,126
Goodwill278,191577,896
Intangible assets, net213,574244,690
Deferred contract acquisition costs9,9817,205
Other assets1,3171,678
Total assets913,7911,285,529
Current liabilities:  
Accounts payable9,9877,837
Accrued expenses and other current liabilities11,02611,000
Accrued compensation35,46739,189
Due to customers9,24416,263
Current portion of deferred revenue43,50030,875
Current portion of operating lease liabilities7,3926,589
Total current liabilities116,616111,753
Loans payable, net of unamortized issuance costs281,914280,666
Operating lease liabilities28,84932,486
Other noncurrent liabilities2034,562
Deferred revenue256268
Total liabilities427,838429,735
Commitments and Contingencies (note 12)
Stockholders' equity  
Common stock par value $0.0001; 500,000,000 shares authorized; 72,390,727 and 67,098,477 shares issued and outstanding at November 30, 2022 and February 28, 2022, respectively77
Additional paid-in capital1,409,8071,350,431
Accumulated deficit(923,861)(494,644)
Total stockholders' equity485,953855,794
Total liabilities and stockholders' equity$ 913,791$ 1,285,529